|
Proinflammatory markers investigated in the temporal and spatial progression of early AD pathogenesis. Immune cell molecules/inflammatory markers were assessed from RNA isolated from entorhinal cortex and hippocampus tissue of 2, 3, and 6 month-old 3xTg-AD and non-transgenic mice by qRT-PCR using Applied Biosystems Microfluidic Cards. |
|
| Immune Marker |
Major Functions |
|
|
|
| C3 |
complement protein, binds to pathogenic structures |
| CCL2 (MCP-1) |
chemokine, promotes extravasation, activates macrophages, promotes Th2 immunity |
| CCL3 |
chemokine, promotes extravasation, antiviral defense, promotes Th1 immunity |
| Fractalkine |
chemokine, involved in brain inflammation, endothelial adhesion |
| IP10 |
chemokine, antiangiogenic, promotes Th1 immmunity |
| TNF-α |
cytokine, proinflammatory, attracts innate immune cells, activates macrophages |
| TGF-β |
cytokine, inhibits cell growth |
| IL-2 |
cytokine, T cell growth factor |
| IL-6 |
cytokine, B and T cell growth and differentiation |
| IL-8 |
cytokine, secreted by macrophage(predominately in response to bacterial infection), recruits innate and adaptive immune cells |
| IL-1α |
cytokine, macrophage and T cell activation |
| IL-1β |
cytokine, macrophage and T cell activation |
| IL-12a |
cytokine, activates NK cells, induces CD4 differentiation to Th1 cell |
| ICAM 1 |
intercellular adhesion molecule present on endothelial cells, binds LFA-1 and Mac-1 (Cd11b) |
| VCAM 1 |
adhesion molecule present on endothelial cells, binds VLA-4 integrin |
| CD4 |
cell surface marker for TH1 and TH2 T cells, coreceptor for MHC II |
| CD8 |
cell surface marker on cytotoxic T cells, coreceoptor for MHC I |
| CD80 |
cell surface marker, T cell/antigen presenting cell costimulation |
| CD86 |
cell surface marker, T cell/antigen presenting cell costimulation |
| Ptgs1 |
Cyclooxygenase type 1 (Cox-1) |
| Ptgs2 |
Cyclooxygenase type 2 (Cox-2) |
| Caspase 3 |
late-stage molecule involved in apoptosis |
Janelsins et al. Journal of Neuroinflammation 2005 2:23 doi:10.1186/1742-2094-2-23 |
|